Stockscreener 앱 받기
89.83
0.51%
-0.46
시장 영업 전:
90.60
0.77
+0.86%
Astrazeneca PLC 주식(AZN)의 최신 뉴스
Geneos Wealth Management Inc. Grows Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
Holocene Advisors LP Sells 124,752 Shares of AstraZeneca PLC $AZN - MarketBeat
Rexford Capital Inc. Invests $948,000 in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca Unveils Sweeping Blood Cancer Push With Record ASH Presence - MyChesCo
AstraZeneca PLC $AZN Shares Bought by Cubist Systematic Strategies LLC - MarketBeat
AstraZeneca PLC $AZN Shares Bought by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
GSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients - Benzinga
AstraZeneca (AZN) At the Center of Serious Analyst Attention - Insider Monkey
Parkwood LLC Buys 112,053 Shares of AstraZeneca PLC $AZN - MarketBeat
Swedish Stocks in North America – AstraZeneca Drops 0.8 Percent - marketscreener.com
AstraZeneca PLC ADR Falls Thursday, Underperforms Market - 富途牛牛
Details trickle in about salary, size at AstraZeneca's new Albemarle plant - Richmond Times-Dispatch
Is the Market Bullish or Bearish on AstraZeneca PLC? - Benzinga
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.01 Million Stake in AstraZeneca PLC $AZN - MarketBeat
Why is AstraZeneca PLC (AZN) one of the best pharma stocks to invest in? - MSN
Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In? - Insider Monkey
AstraZeneca: A Rare Compound Growth Opportunity In Biopharma (AZN) - Seeking Alpha
60,378 Shares in AstraZeneca PLC $AZN Bought by Norges Bank - MarketBeat
Aug Ideas: Will Precidian ETFs Trust AstraZeneca PLC stock maintain strong growthJuly 2025 Sector Moves & Smart Allocation Stock Reports - moha.gov.vn
AstraZeneca price target raised to $105 from $95 at TD Cowen on growth outlook - Investing.com UK
AstraZeneca (AZN) Begins Phase 3 Trial of Enhertu for Ovarian Ca - GuruFocus
Quantbot Technologies LP Reduces Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Sold by Hsbc Holdings PLC - MarketBeat
Cerity Partners LLC Increases Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Acquired by Fayez Sarofim & Co - MarketBeat
AstraZeneca (LSE:AZN): Assessing Valuation After a Strong Year-to-Date Share Price Rally - Yahoo Finance
AstraZeneca PLC (NASDAQ:AZN) Nasdaq Futures Science-Driven Growth - Kalkine Media
AstraZeneca PLC ADR Rises Monday, Outperforms Market - 富途牛牛
Pillar Biosciences and AstraZeneca expand liquid biopsy access partnership to China - marketscreener.com
Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Access Partnership to China - marketscreener.com
AstraZeneca is top pharma tip for 2026, with GSK left trailing - Proactive Investors
How Are AstraZeneca’s Scientific Initiatives Influencing Its FTSE 100 Standing? - Kalkine Media
AstraZeneca (AZN) Price Target Raised by JPMorgan - GuruFocus
First Trust Advisors LP Acquires 217,595 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Bought by Invesco Ltd. - MarketBeat
1832 Asset Management L.P. Acquires 18,543 Shares of AstraZeneca PLC $AZN - MarketBeat
Surprises Report: Is AstraZeneca PLC ZEG stock resilient in recession scenariosLong Setup & High Accuracy Investment Signals - BỘ NỘI VỤ
AstraZeneca PLC $AZN Shares Sold by Capital Fund Management S.A. - MarketBeat
AstraZeneca: An Insight Into The Growth Potential Of Imfinzi - Smartkarma
SCS Capital Management LLC Purchases 142,331 Shares of AstraZeneca PLC $AZN - MarketBeat
Marshall Wace LLP Buys 623,902 Shares of AstraZeneca PLC $AZN - MarketBeat
Guggenheim Capital LLC Has $13.58 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
UK stocks gain ahead of key US inflation data; AstraZeneca rises - marketscreener.com
Is AstraZeneca PLC (Common Stock) (ZEGA) stock a buy on weaknessWeekly Profit Summary & Fast Gain Stock Tips - Newser
Epoch Investment Partners Inc. Trims Position in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca selects Salesforce’s Agentforce for global HCP engagement By Investing.com - Investing.com Nigeria
Is Precidian ETFs Trust AstraZeneca PLC stock a top dividend aristocrat candidateTrade Risk Assessment & Expert Approved Momentum Trade Ideas - Newser
Why Precidian ETFs Trust AstraZeneca PLC stock benefits from AI revolutionQuarterly Investment Review & AI Enhanced Execution Alerts - Newser
Has AstraZeneca’s Strong 30% Rally Left Further Upside in 2025? - Yahoo Finance
Salesforce’s Agentforce Life Sciences Selected by AstraZeneca as Its Unified Global Platform to Help Transform Customer Engagement - Yahoo Finance
AstraZeneca Stake Adjustment by Capital Group - TipRanks
AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report - Sahm
ASTRAZENECA : Bernstein remains its Buy rating - marketscreener.com
FDA Streamlines Clinical Study Requirements, Impacting AstraZene - GuruFocus
AstraZeneca (AZN) Could Benefit from FDA's Shift to Single Study Approval - GuruFocus
REGAstraZeneca PLCHolding(s) in Company - TradingView
AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH - marketscreener.com
Neurimmune expands collaboration with AstraZeneca to develop and commercialize Fibril Depleter NI009 for AL Amyloidosis - marketscreener.com
AstraZeneca news live: price tests Ichimoku Kijun support — bullish momentum meets consolidation risks - Traders Union
M&T Bank Corp Has $15.30 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
Bernstein Maintains ASTRAZENECA PLC(AZNCF.US) With Buy Rating, Raises Target Price to $245.46 - 富途牛牛
AstraZeneca PLC Advances Hematology and Cell Therapy Ambition with Largest-Ever Presence at ASH - marketscreener.com
AstraZeneca (AZN) Set to Showcase Hematology Innovations at ASH 2025 - GuruFocus
New York State Common Retirement Fund Has $13.74 Million Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca to showcase hematology advances at ASH annual meeting By Investing.com - Investing.com UK
Arrowstreet Capital Limited Partnership Cuts Position in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca (Nasdaq: AZN) taps Salesforce Agentforce to unify global HCP engagement - Stock Titan
Guggenheim Maintains ASTRAZENECA PLC(AZNCF.US) With Buy Rating, Raises Target Price to $206.76 - 富途牛牛
자본화:
|
볼륨(24시간):